The smoking cessation pill, varenicline, has emerged as a groundbreaking solution for those struggling with nicotine addiction, particularly among teenagers and young adults.Recently highlighted in a study by Mass General Brigham, this FDA-approved medication has shown remarkable efficacy, helping users quit vaping at rates three times higher than those who relied solely on behavioral counseling.